Spns2-targeted therapy for multiple sclerosis via S1P transporter inhibition

A novel therapeutic approach targeting the S1P transporter Spns2 for treatment of multiple sclerosis. Preclinical data in animal models demonstrate that blocking Spns2 inhibits lymphocyte trafficking and reduces neuroinf...